These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
185 related items for PubMed ID: 3528853
1. Prophylactic treatment of very premature infants with human surfactant. Merritt TA, Hallman M, Bloom BT, Berry C, Benirschke K, Sahn D, Key T, Edwards D, Jarvenpaa AL, Pohjavuori M. N Engl J Med; 1986 Sep 25; 315(13):785-90. PubMed ID: 3528853 [Abstract] [Full Text] [Related]
2. A controlled trial of synthetic surfactant in infants weighing 1250 g or more with respiratory distress syndrome. The American Exosurf Neonatal Study Group I, and the Canadian Exosurf Neonatal Study Group. Long W, Corbet A, Cotton R, Courtney S, McGuiness G, Walter D, Watts J, Smyth J, Bard H, Chernick V. N Engl J Med; 1991 Dec 12; 325(24):1696-703. PubMed ID: 1944470 [Abstract] [Full Text] [Related]
3. A multicenter randomized, placebo-controlled trial of surfactant therapy for respiratory distress syndrome. Horbar JD, Soll RF, Sutherland JM, Kotagal U, Philip AG, Kessler DL, Little GA, Edwards WH, Vidyasagar D, Raju TN. N Engl J Med; 1989 Apr 13; 320(15):959-65. PubMed ID: 2648150 [Abstract] [Full Text] [Related]
5. Improving the prediction of surfactant deficiency in very low-birthweight infants with respiratory distress. Harker LC, Merritt TA, Edwards DK. J Perinatol; 1992 Jun 13; 12(2):129-33. PubMed ID: 1522430 [Abstract] [Full Text] [Related]
6. Surfactant replacement therapy for severe neonatal respiratory distress syndrome: an international randomized clinical trial. Collaborative European Multicenter Study Group. Pediatrics; 1988 Nov 13; 82(5):683-91. PubMed ID: 2903480 [Abstract] [Full Text] [Related]
7. [Surfactant substitution in very small premature infants]. Obladen M, Segerer H. Monatsschr Kinderheilkd; 1991 Jan 13; 139(1):2-15. PubMed ID: 2030695 [Abstract] [Full Text] [Related]
9. Surfactant replacement therapy with a single postventilatory dose of a reconstituted bovine surfactant in preterm neonates with respiratory distress syndrome: final analysis of a multicenter, double-blind, randomized trial and comparison with similar trials. The Surfactant-TA Study Group. Fujiwara T, Konishi M, Chida S, Okuyama K, Ogawa Y, Takeuchi Y, Nishida H, Kito H, Fujimura M, Nakamura H. Pediatrics; 1990 Nov 13; 86(5):753-64. PubMed ID: 2235230 [Abstract] [Full Text] [Related]
10. Multicenter trial of single-dose modified bovine surfactant extract (Survanta) for prevention of respiratory distress syndrome. Ross Collaborative Surfactant Prevention Study Group. Soll RF, Hoekstra RE, Fangman JJ, Corbet AJ, Adams JM, James LS, Schulze K, Oh W, Roberts JD, Dorst JP. Pediatrics; 1990 Jun 13; 85(6):1092-102. PubMed ID: 2187176 [Abstract] [Full Text] [Related]
11. Double-blind, randomized trial of a calf lung surfactant extract administered at birth to very premature infants for prevention of respiratory distress syndrome. Shapiro DL, Notter RH, Morin FC, Deluga KS, Golub LM, Sinkin RA, Weiss KI, Cox C. Pediatrics; 1985 Oct 13; 76(4):593-9. PubMed ID: 3900907 [Abstract] [Full Text] [Related]
12. Does prophylactic use of bovine surfactant change drug utilization in very premature infants during neonatal period? Gortner L, Bernsau U, Hellwege HH, Hieronimi G, Jorch G, Reiter HL. Dev Pharmacol Ther; 1991 Oct 13; 16(1):1-6. PubMed ID: 1879246 [Abstract] [Full Text] [Related]
13. Improved neonatal survival following multiple doses of bovine surfactant in very premature neonates at risk for respiratory distress syndrome. Hoekstra RE, Jackson JC, Myers TF, Frantz ID, Stern ME, Powers WF, Maurer M, Raye JR, Carrier ST, Gunkel JH. Pediatrics; 1991 Jul 13; 88(1):10-8. PubMed ID: 2057245 [Abstract] [Full Text] [Related]
14. Nasal CPAP or intubation at birth for very preterm infants. Morley CJ, Davis PG, Doyle LW, Brion LP, Hascoet JM, Carlin JB, COIN Trial Investigators. N Engl J Med; 2008 Feb 14; 358(7):700-8. PubMed ID: 18272893 [Abstract] [Full Text] [Related]
15. Inositol supplementation in premature infants with respiratory distress syndrome. Hallman M, Bry K, Hoppu K, Lappi M, Pohjavuori M. N Engl J Med; 1992 May 07; 326(19):1233-9. PubMed ID: 1560798 [Abstract] [Full Text] [Related]
16. Inhaled nitric oxide for premature infants with severe respiratory failure. Van Meurs KP, Wright LL, Ehrenkranz RA, Lemons JA, Ball MB, Poole WK, Perritt R, Higgins RD, Oh W, Hudak ML, Laptook AR, Shankaran S, Finer NN, Carlo WA, Kennedy KA, Fridriksson JH, Steinhorn RH, Sokol GM, Konduri GG, Aschner JL, Stoll BJ, D'Angio CT, Stevenson DK, Preemie Inhaled Nitric Oxide Study. N Engl J Med; 2005 Jul 07; 353(1):13-22. PubMed ID: 16000352 [Abstract] [Full Text] [Related]
17. Animal derived surfactant extract for treatment of respiratory distress syndrome. Seger N, Soll R. Cochrane Database Syst Rev; 2009 Apr 15; (2):CD007836. PubMed ID: 19370695 [Abstract] [Full Text] [Related]
18. Death postponement and increased chronic lung disease: the hidden costs of mortality reduction in the post-surfactant era. Wright K. J Assoc Acad Minor Phys; 1999 Apr 15; 10(4):82-7. PubMed ID: 10826014 [Abstract] [Full Text] [Related]
19. A controlled trial of dexamethasone to prevent bronchopulmonary dysplasia in surfactant-treated infants. Rastogi A, Akintorin SM, Bez ML, Morales P, Pildes RS. Pediatrics; 1996 Aug 15; 98(2 Pt 1):204-10. PubMed ID: 8692619 [Abstract] [Full Text] [Related]
20. A comparison of surfactant as immediate prophylaxis and as rescue therapy in newborns of less than 30 weeks' gestation. Kendig JW, Notter RH, Cox C, Reubens LJ, Davis JM, Maniscalco WM, Sinkin RA, Bartoletti A, Dweck HS, Horgan MJ. N Engl J Med; 1991 Mar 28; 324(13):865-71. PubMed ID: 2000109 [Abstract] [Full Text] [Related] Page: [Next] [New Search]